XML 33 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated statements of cash flows - indirect method - BRL (R$)
R$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities      
Net income from continuing operations R$ 2,525,900 R$ 2,517,753 R$ 1,538,211
Adjustments to reconcile net income to cash provided (consumed) by operating activities      
Share of profit (loss) of subsidiaries, joint ventures and associates and amortization of fair value adjustments on associates acquisition 129,675 (11,908) (12,181)
Amortization of contractual assets with customers - exclusivity rights 555,083 607,446 504,907
Amortization of right-of-use assets 312,060 305,900 288,419
Depreciation and amortization 900,673 848,894 738,904
Interest, derivatives, monetary variations and foreign exchange variations 1,557,814 1,349,953 1,625,987
Current and deferred income and social contribution taxes 1,485,617 1,060,942 341,514
Gain (loss) on disposal or write-off of property, plant and equipment, intangible assets and other assets (207,076) (192,744) (322,190)
Equity instrument granted 57,458 38,909 9,944
Gain (loss) on the fair value of energy contracts (64,287) 0 0
Provision for decarbonization - CBIO and carbon credits 584,371 740,298 638,542
Other provisions and adjustments (16,069) 147,800 44,793
Cash flows from operations before changes in working capital 7,821,219 7,413,243 5,396,850
(Increase) decrease in assets      
Trade receivables and reseller financing 180,339 259,878 (779,239)
Inventories 371,244 645,301 (1,004,819)
Recoverable taxes (1,642,714) (1,201,440) (2,056,104)
Dividends received from subsidiaries, associates and joint ventures 2,028 12,041 146
Other assets (114,528) (87,797) (224,379)
Increase (decrease) in liabilities      
Trade payables and trade payables - reverse factoring (1,209,636) (1,700,496) 1,557,837
Salaries and related charges (17,019) 30,965 130,586
Taxes payable (23,512) (25,027) (9,442)
Other liabilities (160,331) 218,523 677,016
Acquisition of CBIO and carbon credits (713,453) (778,885) (635,130)
Payments of contractual assets with customers - exclusivity rights (418,250) (597,798) (710,908)
Payment of contingencies (30,896) (70,128) (84,939)
Income and social contribution taxes paid (308,915) (268,558) (283,331)
Net cash provided by operating activities from continuing operations 3,735,576 3,849,822 1,974,144
Net cash provided by operating activities from discontinued operations 0 0 30,550
Net cash provided by operating activities 3,735,576 3,849,822 2,004,694
Cash flows from investing activities      
Financial investments, net of redemptions (4,202,032) 73,973 1,567,962
Acquisition of property, plant and equipment and intangible assets (1,787,175) (1,287,330) (1,206,836)
Receipt of intercompany loan owed by Oxiteno S.A. to Ultrapar International 0 0 3,980,699
Cash provided by disposal of investments and property, plant and equipment 1,386,252 512,827 2,839,676
Capital increase in joint ventures 0 0 (28,000)
Capital decrease in joint ventures 522 3,100 0
Net cash consumed in the purchase of investments and other assets (1,785,517) (324,125) 969,790
Net cash provided (consumed) by investing activities from continuing operations (6,387,950) (1,021,555) 8,123,291
Net cash consumed by investing activities from discontinued operations 0 0 (220,190)
Net cash provided (consumed) by investing activities (6,387,950) (1,021,555) 7,903,101
Loans, financing and debentures      
Proceeds 4,179,974 2,903,031 1,519,580
Repayments (2,718,953) (3,149,525) (5,848,611)
Interest and derivatives (paid) or received (1,117,562) (1,267,447) (1,398,229)
Payments of lease      
Principal (285,404) (213,527) (351,011)
Interest paid (148,084) (145,586) (6,868)
Dividends paid (833,658) (400,025) (638,280)
Proceeds from financial liabilities of customers 0 7,812 162,895
Payments of financial liabilities of customers (159,897) (197,891) (173,948)
Capital increase made by non-controlling shareholders and redemption of shares 13,500 0 21,682
Repurchase of treasury shares (148,945) 0 0
Related parties (15,073) (31,238) (18,926)
Net cash consumed by financing activities from continuing operations (1,234,102) (2,494,396) (6,731,716)
Net cash consumed by financing activities from discontinued operations 0 0 (179,025)
Net cash consumed by financing activities (1,234,102) (2,494,396) (6,910,741)
Effect of exchange rate changes on cash and cash equivalents in foreign currency - continuing operations 32,381 (29,952) (24,024)
Effect of exchange rate changes on cash and cash equivalents in foreign currency - discontinued operations 0 0 (19,316)
Increase (decrease) in cash and cash equivalents – continuing operations (3,854,095) 303,919 3,341,695
Decrease in cash and cash equivalents - discontinued operations 0 0 (387,981)
Cash and cash equivalents at the beginning of the year – continuing operations 5,925,688 5,621,769 2,280,074
Cash and cash equivalents at the beginning of the year – discontinuied operations 0 0 387,981
Cash and cash equivalents at the end of the year – continuing operations 2,071,593 5,925,688 5,621,769
Cash and cash equivalents at the end of the year – discontinued operations 0 0 0
Non-cash transactions:      
Addition on right-of-use assets and leases payable 342,332 257,201 482,439
Addition on contractual assets with customers - exclusivity rights 5,627 66,565 63,061
Reclassification between financial assets and investment in associates 645,333 0 0
Transfer between trade receivables and other assets accounts 0 25,646 0
Issuance of shares related to the subscription warrants - indemnification - Extrafarma acquisition 6,452 411 942
Acquisition of property, plant and equipment and intangible assets without cash effect 42,180 104,177 0
Withdrawal of escrow deposits with tax contingencies 610,168 0 41,888
Contingent consideration – acquisition of subsidiaries 0 0 89,640
Capital increase performed by non-controlling interests 0 0 13,519
Reversal fund - private pension R$ 0 R$ 0 R$ 3,107